lincoln-pharmaceuticals-ltd
Home
Lincoln Pharmaceuticals Ltd
LINCOLN Share Price
BSE:
NSE:LINCOLN
LINCOLN Share Price
BSE:
NSE:LINCOLN
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹1,858.46 Cr
PE Ratio
19.23
Lincoln Pharmaceuticals Ltd Performance
▲
▲
▲
▲
Lincoln Pharmaceuticals Ltd Fundamentals
Lincoln Pharmaceuticals Ltd Delivery and Volume
About Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95. All the assets and business of the erstwhile partnershi
| Name | Designation |
|---|---|
| Kishorbhai M Shah | Chairman (Non-Executive) |
| Mahendra G Patel | Managing Director |
| Hasmukhbhai I Patel | Whole-time Director |
| Pirabhai R Suthar | Independent Director |
| Munjal Mahendrabhai Patel | Whole-time Director |
| Aashish R Patel | Whole-time Director |
| Meha Patel | Independent Director |
| Saurin J Parikh | Independent Director |
| Rajnikant G Patel | Director |
| Anand Arvindbhai Patel | Whole-time Director |
| Trusha Shah | Company Sec. & Compli. Officer |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Lincoln Pharmaceuticals Ltd FAQs
How do I Buy Lincoln Pharmaceuticals Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Lincoln Pharmaceuticals Ltd shares in BlinkX.
What is the Share Price of Lincoln Pharmaceuticals Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Lincoln Pharmaceuticals Ltd's share price is ₹929.85 as of 2024-12-14.
What is the PE ratio of Lincoln Pharmaceuticals Ltd?
Lincoln Pharmaceuticals Ltd's P/E ratio is 19.23 times as of 2024-12-14.
What is the PB ratio of Lincoln Pharmaceuticals Ltd?
Lincoln Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 2.91, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Lincoln Pharmaceuticals Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Lincoln Pharmaceuticals Ltd's market capitalization is ₹1858.46 Cr as on 2024-12-14.
What is the ROE of Lincoln Pharmaceuticals Ltd?
The current financial records of Lincoln Pharmaceuticals Ltd show a 17.04% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Lincoln Pharmaceuticals Ltd?
According to Lincoln Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹308.57, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Lincoln Pharmaceuticals Ltd?
The 52-week high/low price of a Lincoln Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Lincoln Pharmaceuticals Ltd's 52-week high and low as of 2024-12-14 are ₹932.95 and ₹902, respectively.
